Histoplasma seropositivity and environmental risk factors for exposure in a general population in Upper River Region, The Gambia: A cross-sectional study

被引:1
作者
Cornell, Tessa Rose [1 ]
Conteh, Bakary [2 ]
Drammeh, Lamin [2 ]
Jeffang, Foday [2 ]
Sallah, Ebrima [2 ]
Kijera, Alkali [2 ]
Jarju, Mustapha [2 ]
Karim, Mehrab [2 ]
Khan, Ebrima [2 ]
Ceesay, Pa Ousman [3 ]
Manneh, Ebrima [3 ]
Wootton, Dan G. [1 ,5 ]
Pinchbeck, Gina [1 ]
Scantlebury, Claire Elizabeth [1 ]
机构
[1] Univ Liverpool, Inst Infect Vet & Ecol Sci IVES, Liverpool CH64 7TE, England
[2] London Sch Hyg & Trop Med, Med Res Council Unit The Gambia, Fajara, Gambia
[3] Minist Finance & Econ Affairs, Gambia Bur Stat GBoS, Serekunda, Gambia
[4] Minist Hlth, Reg Hlth Directorate Upper River Reg, Banjul, Gambia
[5] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Dis, Liverpool, England
基金
英国惠康基金;
关键词
Histoplasma; Seroprevalence; Human-animal-environment interface; One health; The Gambia; CUTANEOUS HISTOPLASMOSIS; NATURAL FOCUS; DUBOISII; IMMUNOGLOBULIN; INFECTION;
D O I
10.1016/j.onehlt.2024.100717
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Robust surveillance of Histoplasma species is warranted in endemic regions, including investigation of community-level transmission dynamics. This cross-sectional study explored anti- Histoplasma antibody seroprevalence and risk factors for exposure in a general population in Upper River Region (URR), The Gambia. Study participants were recruited (December 2022-March 2023) by random household sampling across 12 Enumeration Areas (EAs) of URR. A questionnaire and clinical examination were performed; exploring demographic, clinical and environmental risk factors for Histoplasma exposure. One venous blood sample per participant was subject to IMMY Latex Agglutination Histoplasma test to determine presence of a recent IgM response to Histoplasma. . Seropositivity risk factors were explored by multi-level, multivariable logistic regression analysis. The study population (n n = 298) aged 5-83 years, demonstrated a positively skewed age distribution and comprised 55.4% females. An apparent seroprevalence of 18.8% (n n = 56/298, 95% CI 14.5-23.7%) was measured using the LAT. A multivariable model demonstrated increased odds of Histoplasma seropositivity amongst female participants (OR = 2.41 95% CI 1.14-5.10); and participants reporting involvement in animal manure management (OR = 4.21 95% CI 1.38-12.90), and management of domestic animals inside the compound at night during the dry season (OR = 10.72 95% CI 2.02-56.83). Increasing age (OR = 0.96 95% CI 0.93-0.98) was associated with decreased odds of seropositivity. Clustering at EA level was responsible for 17.2% of seropositivity variance. The study indicates frequent recent Histoplasma exposure and presents plausible demographic and environmental risk factors for seropositivity. Histoplasma spp. characterisation at this human-animal-environment interface is warranted, to determine public health implications of environmental reservoirs in The Gambia. The study was supported by Wellcome Trust (206,638/Z/17/Z to CES) and a University of Liverpool-funded PhD studentship (to TRC).
引用
收藏
页数:8
相关论文
共 50 条
  • [21] EVALUATION OF A MICROTITER LATEX AGGLUTINATION TEST FOR HISTOPLASMOSIS
    GERBER, JD
    RILEY, RE
    JONES, RD
    [J]. APPLIED MICROBIOLOGY, 1972, 24 (02) : 191 - +
  • [22] A NATURAL FOCUS OF HISTOPLASMA-CAPSULATUM VAR DUBOISII IS A BAT CAVE
    GUGNANI, HC
    MUOTOEOKAFOR, FA
    KAUFMAN, L
    DUPONT, B
    [J]. MYCOPATHOLOGIA, 1994, 127 (03) : 151 - 157
  • [23] Clinicopathological features of cutaneous histoplasmosis in human immunodeficiency virus-infected patients in Zimbabwe
    Gumbo, T
    Just-Nübling, G
    Robertson, V
    Latif, AS
    Borok, MZ
    Hohle, R
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (06) : 635 - 636
  • [24] Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons
    Hajjeh, RA
    Pappas, PG
    Henderson, H
    Lancaster, D
    Bamberger, DM
    Skahan, KJ
    Phelan, MA
    Cloud, G
    Holloway, M
    Kauffman, CA
    Wheat, LJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) : 1215 - 1220
  • [25] HILL GRACE B., 1962, MYCOPATHOL ET MYCOL APPL, V18, P169, DOI 10.1007/BF02051586
  • [26] IMMY, 2018, LA-Coccidioides, LA-Histoplasma,and LA-Sporothrix Antibody Systems, IMMY Packag
  • [27] Histoplasmosis: a clinical and laboratory update
    Kauffman, Carol A.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (01) : 115 - +
  • [28] Kipyegon KE., 2017, Eur. Sci. J., V13, P119, DOI [10.19044/esj.2017.v13n15p119, DOI 10.19044/ESJ.2017.V13N15P119]
  • [29] Diagnosing disseminated histoplasmosis in advanced HIV/AIDS disease in Cameroon using a point of care lateral flow assay
    Kuate, Marius Paulin Ngouanom
    Abessolo, Hermine Abessolo
    Denning, David W.
    Stone, Neil R.
    Ndip, Roland Ndip
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [30] Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum
    Lin, JS
    Yang, CW
    Wang, DW
    Wu-Hsieh, BA
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (10) : 6282 - 6291